REFERENCES
  1. Allam MF, Del Castillo AS, Díaz-Molina C, Navajas RF. Invasive pulmonary aspergillosis: identification of risk factors. Scand J Infect Dis. 2002;34(11):819-22. doi: 10.1080/0036554021000026954. PMID: 12578151.
  2. Geltner C, Lass-Flörl C. Invasive pulmonary Aspergillosis in organ transplants–Focus on lung transplants. RespirInvestig. 2016 Mar;54(2):76-84. doi: 10.1016/j.resinv.2015.08.005. Epub 2015 Nov 10. PMID: 26879476.
  3. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003;17(1):113–34
  4. deVrankrijker AM, van der Ent CK, van Berkhout FT, Stellato RK, Willems RJ, Bonten MJ, Wolfs TF. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? ClinMicrobiol Infect. 2011 Sep;17(9):1381-6. doi: 10.1111/j.1469-0691.2010.03429.x. Epub 2010 Dec 16. PMID: 21087348.
  5. Burgel PR, Paugam A, Hubert D, Martin C. Aspergillus fumigatus  in the cystic fibrosis lung: pros and cons of azole therapy. Infect Drug Resist . 2016;9:229-238. Published 2016 Sep 20. doi:10.2147/IDR.S63621
  6. Garcia-Vidal C, Alastruey-Izquierdo A, Aguilar-Guisado M, Carratalà J, Castro C, Fernández-Ruiz M, Aguado JM, Fernández JM, Fortún J, Garnacho-Montero J, Gavaldà J, Gudiol C, Guinea J, Gómez-López A, Muñoz P, Pemán J, Rovira M, Ruiz-Camps I, Cuenca-Estrella M. Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI. EnfermInfeccMicrobiolClin. 2019 Oct;37(8):535-541. English, Spanish. doi: 10.1016/j.eimc.2018.03.018. Epub 2018 Jun 28. PMID: 29960829.
  7. Gubbins PO, Amsden JR. Drug-drug interactions of antifungal agents and implications for patient care. Expert OpinPharmacother. 2005 Oct;6(13):2231-43. doi: 10.1517/14656566.6.13.2231. PMID: 16218884.
  8. Wang T, Zhu H, Sun J, Cheng X, Xie J, Dong H, Chen L, Wang X, Xing J, Dong Y. Efficacy and safety of voriconazolee and CYP2C19 polymorphism for optimised dosage regimens in patients with invasive fungal infections. Int J Antimicrob Agents. 2014 Nov;44(5):436-42. doi: 10.1016/j.ijantimicag.2014.07.013. Epub 2014 Aug 30. PMID: 25239277.
  9. Felton T, Troke PF, Hope WW. Tissue penetration of antifungal agents. Clin Microbiol Rev. 2014 Jan;27(1):68-88. doi: 10.1128/CMR.00046-13. PMID: 24396137; PMCID: PMC3910906.
  10. Monforte V, Ussetti P, Gavaldà J, Bravo C, Laporta R, Len O, García-Gallo CL, Tenorio L, Solé J, Román A. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation. J Heart Lung Transplant. 2010 May;29(5):523-30. doi: 10.1016/j.healun.2009.11.603. Epub 2010 Jan 12. PMID: 20061165.
  11. Tolman JA, Nelson NA, Son YJ, Bosselmann S, Wiederhold NP, Peters JI, McConville JT, Williams RO 3rd. Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution. Eur J Pharm Biopharm. 2009 May;72(1):199-205. doi: 10.1016/j.ejpb.2008.12.014. PMID: 19348016.
  12. Le J, Ashley ED, Neuhauser MM, Brown J, Gentry C, Klepser ME, et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2010;30(6):562-84. DOI: 10.1592/phco.30.6.562
  13. Guía de buenas prácticas de preparación de medicamentos en servicios de farmacia hospitalaria. MINISTERIO DE SANIDAD, SERVICIOS SOCIALES E IGUALDAD.2014. Available at:https://www.sefh.es/sefhpdfs/GuiaBPP_JUNIO_2014_VF.pdf
  14. Dupuis A, Tournier N, Le Moal G, Venisse N. Preparation and stability of voriconazolee eye drop solution. Antimicrob Agents Chemother 2009; 53, 2: 798-799.
  15. Amorós-Reboredo P, Bastida-Fernandez C, Guerrero-Molina L, Soy-Muner D, López-Cabezas C. Stability of frozen 1% voriconazolee ophthalmic solution. Am J Health-Syst Pharm ; 72:479-482 2015
  16. Sahraoui L, Chiadmi F, Schlatter J, Toledano A, Cisternino S, Fontan JE. Stability of voriconazolee injection in 0.9% sodium chloride and 5% dextrose injections. Am J Health-SystPharm ; 63: 1423-1426. 2006
  17. Adams, A.I.H., Morimoto, L.N., Meneghini, L.Z., Bergold, A.M. Treatment of invasive fungal infections: Stability of voriconazole infusion solutions in PVC bags. BJID ; 12, 5: 400-404. 2008
  18. Holle J, Leichsenring M, Meissner PE. Nebulized voriconazole in infections with Scedosporiumapiospermum–case report and review of the literature. J Cyst Fibros. 2014 Jul;13(4):400-2. doi: 10.1016/j.jcf.2013.10.014. Epub 2013 Nov 18. PMID: 24263169.
  19. Hilberg O, Andersen CU, Henning O, Lundby T, Mortensen J, Bendstrup E. Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis. EurRespir J. 2012 Jul;40(1):271-3. doi: 10.1183/09031936.00163511. PMID: 22753838.